Lexicon Pharmaceuticals, Inc. (LXRX)
2.23
+0.02
(+0.90%)
USD |
NASDAQ |
May 21, 16:00
2.225
0.00 (0.00%)
After-Hours: 19:59
Lexicon Pharmaceuticals Research and Development Expense (TTM) : 58.02M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.70M |
| Liquidia Corp. | 44.01M |
| Novo Nordisk A/S | 8.079B |
| Emmaus Life Sciences, Inc. | 0.177M |
| Nutriband, Inc. | 1.891M |